$EICU Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VISICU INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in VISICU INC. Get notifications about new insider transactions in VISICU INC for free.
Page: < prev 1 2 3 4 5 6 6 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 02 2007 | EICU | VISICU INC | Estrada Vincent E | Sr VP and CFO | Sell | S | 8.61 | 100 | 861 | 1,100 | 1.2 K to 1.1 K (-8.33 %) |
| May 02 2007 | EICU | VISICU INC | Estrada Vincent E | Sr VP and CFO | Sell | S | 8.62 | 300 | 2,586 | 1,200 | 1.5 K to 1.2 K (-20.00 %) |
| May 02 2007 | EICU | VISICU INC | Estrada Vincent E | Sr VP and CFO | Sell | S | 8.63 | 300 | 2,589 | 1,500 | 1.8 K to 1.5 K (-16.67 %) |
| May 02 2007 | EICU | VISICU INC | Estrada Vincent E | Sr VP and CFO | Sell | S | 8.67 | 300 | 2,601 | 1,800 | 2.1 K to 1.8 K (-14.29 %) |
| May 02 2007 | EICU | VISICU INC | Estrada Vincent E | Sr VP and CFO | Sell | S | 8.89 | 300 | 2,667 | 2,100 | 2.4 K to 2.1 K (-12.50 %) |
| May 02 2007 | EICU | VISICU INC | Estrada Vincent E | Sr VP and CFO | Sell | S | 8.98 | 600 | 5,388 | 2,400 | 3 K to 2.4 K (-20.00 %) |
| May 02 2007 | EICU | VISICU INC | Estrada Vincent E | Sr VP and CFO | Buy | M | 1.80 | 3,000 | 5,400 | 3,000 | 0 to 3 K |
| May 02 2007 | EICU | VISICU INC | Estrada Vincent E | Sr VP and CFO | Sell | S | 10.00 | 1,000 | 10,000 | 0 | 1,000 to 0 (-100.00 %) |
| May 02 2007 | EICU | VISICU INC | Estrada Vincent E | Sr VP and CFO | Buy | M | 1.80 | 1,000 | 1,800 | 1,000 | 0 to 1,000 |
| Apr 24 2007 | EICU | VISICU INC | SAMPLE FRANK T | Chairman and CEO | Option Exercise | M | 0.35 | 10,000 | 3,500 | 685,000 | |
| Apr 24 2007 | EICU | VISICU INC | SAMPLE FRANK T | Chairman and CEO | Sell | S | 8.00 | 10,000 | 80,000 | 918,500 | 928.5 K to 918.5 K (-1.08 %) |
| Apr 24 2007 | EICU | VISICU INC | SAMPLE FRANK T | Chairman and CEO | Buy | M | 0.35 | 10,000 | 3,500 | 928,500 | 918.5 K to 928.5 K (+1.09 %) |
| Apr 24 2007 | EICU | VISICU INC | Estrada Vincent E | Sr VP and CFO | Option Exercise | M | 1.80 | 6,000 | 10,800 | 303,000 | |
| Apr 24 2007 | EICU | VISICU INC | Estrada Vincent E | Sr VP and CFO | Sell | S | 8.00 | 6,000 | 48,000 | 0 | 6 K to 0 (-100.00 %) |
| Apr 24 2007 | EICU | VISICU INC | Estrada Vincent E | Sr VP and CFO | Buy | M | 1.80 | 6,000 | 10,800 | 6,000 | 0 to 6 K |
| Apr 24 2007 | EICU | VISICU INC | Rosenfeld Brian A | EVP and CMO | Sell | S | 8.00 | 10,000 | 80,000 | 450,000 | 460 K to 450 K (-2.17 %) |
| Apr 24 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 8.00 | 4,796 | 38,368 | 273,288 | 278.1 K to 273.3 K (-1.72 %) |
| Apr 24 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 8.00 | 4,796 | 38,368 | 545,212 | 550 K to 545.2 K (-0.87 %) |
| Mar 27 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 8.00 | 204 | 1,632 | 278,084 | 278.3 K to 278.1 K (-0.07 %) |
| Mar 27 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 8.00 | 204 | 1,632 | 550,008 | 550.2 K to 550 K (-0.04 %) |
| Mar 27 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | J | 0.00 | 101,712 | 0 | 278,288 | 380 K to 278.3 K (-26.77 %) |
| Mar 27 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Buy | J | 0.00 | 101,712 | 0 | 550,212 | 448.5 K to 550.2 K (+22.68 %) |
| Feb 09 2007 | EICU | VISICU INC | SAMPLE FRANK T | Chairman and CEO | Option Exercise | M | 0.35 | 5,000 | 1,750 | 695,000 | |
| Feb 09 2007 | EICU | VISICU INC | SAMPLE FRANK T | Chairman and CEO | Option Exercise | A | 10.18 | 75,000 | 763,500 | 75,000 | |
| Feb 09 2007 | EICU | VISICU INC | SAMPLE FRANK T | Chairman and CEO | Sell | S | 10.73 | 500 | 5,365 | 918,500 | 919 K to 918.5 K (-0.05 %) |
| Feb 09 2007 | EICU | VISICU INC | SAMPLE FRANK T | Chairman and CEO | Sell | S | 10.75 | 500 | 5,375 | 919,000 | 919.5 K to 919 K (-0.05 %) |
| Feb 09 2007 | EICU | VISICU INC | SAMPLE FRANK T | Chairman and CEO | Sell | S | 10.76 | 900 | 9,684 | 919,500 | 920.4 K to 919.5 K (-0.10 %) |
| Feb 09 2007 | EICU | VISICU INC | SAMPLE FRANK T | Chairman and CEO | Sell | S | 10.77 | 100 | 1,077 | 920,400 | 920.5 K to 920.4 K (-0.01 %) |
| Feb 09 2007 | EICU | VISICU INC | SAMPLE FRANK T | Chairman and CEO | Sell | S | 10.91 | 500 | 5,455 | 920,500 | 921 K to 920.5 K (-0.05 %) |
| Feb 09 2007 | EICU | VISICU INC | SAMPLE FRANK T | Chairman and CEO | Sell | S | 10.94 | 500 | 5,470 | 921,000 | 921.5 K to 921 K (-0.05 %) |
| Feb 09 2007 | EICU | VISICU INC | SAMPLE FRANK T | Chairman and CEO | Sell | S | 10.95 | 500 | 5,475 | 921,500 | 922 K to 921.5 K (-0.05 %) |
| Feb 09 2007 | EICU | VISICU INC | SAMPLE FRANK T | Chairman and CEO | Sell | S | 10.96 | 800 | 8,768 | 922,000 | 922.8 K to 922 K (-0.09 %) |
| Feb 09 2007 | EICU | VISICU INC | SAMPLE FRANK T | Chairman and CEO | Sell | S | 10.97 | 300 | 3,291 | 922,800 | 923.1 K to 922.8 K (-0.03 %) |
| Feb 09 2007 | EICU | VISICU INC | SAMPLE FRANK T | Chairman and CEO | Sell | S | 10.98 | 200 | 2,196 | 923,100 | 923.3 K to 923.1 K (-0.02 %) |
| Feb 09 2007 | EICU | VISICU INC | SAMPLE FRANK T | Chairman and CEO | Sell | S | 10.99 | 200 | 2,198 | 923,300 | 923.5 K to 923.3 K (-0.02 %) |
| Feb 09 2007 | EICU | VISICU INC | SAMPLE FRANK T | Chairman and CEO | Buy | M | 0.35 | 5,000 | 1,750 | 923,500 | 918.5 K to 923.5 K (+0.54 %) |
| Feb 02 2007 | EICU | VISICU INC | Rosenfeld Brian A | EVP and CMO | Option Exercise | A | 10.18 | 65,000 | 661,700 | 65,000 | |
| Feb 02 2007 | EICU | VISICU INC | Rosenfeld Brian A | EVP and CMO | Sell | S | 10.24 | 700 | 7,168 | 460,000 | 460.7 K to 460 K (-0.15 %) |
| Feb 02 2007 | EICU | VISICU INC | Rosenfeld Brian A | EVP and CMO | Sell | S | 10.26 | 1,000 | 10,260 | 460,700 | 461.7 K to 460.7 K (-0.22 %) |
| Feb 02 2007 | EICU | VISICU INC | Rosenfeld Brian A | EVP and CMO | Sell | S | 10.29 | 100 | 1,029 | 461,700 | 461.8 K to 461.7 K (-0.02 %) |
| Feb 02 2007 | EICU | VISICU INC | Rosenfeld Brian A | EVP and CMO | Sell | S | 10.32 | 1,000 | 10,320 | 461,800 | 462.8 K to 461.8 K (-0.22 %) |
| Feb 02 2007 | EICU | VISICU INC | Rosenfeld Brian A | EVP and CMO | Sell | S | 10.33 | 1,000 | 10,330 | 462,800 | 463.8 K to 462.8 K (-0.22 %) |
| Feb 02 2007 | EICU | VISICU INC | Rosenfeld Brian A | EVP and CMO | Sell | S | 10.34 | 1,000 | 10,340 | 463,800 | 464.8 K to 463.8 K (-0.22 %) |
| Feb 02 2007 | EICU | VISICU INC | Rosenfeld Brian A | EVP and CMO | Sell | S | 10.35 | 1,000 | 10,350 | 464,800 | 465.8 K to 464.8 K (-0.21 %) |
| Feb 02 2007 | EICU | VISICU INC | Rosenfeld Brian A | EVP and CMO | Sell | S | 10.38 | 1,900 | 19,722 | 465,800 | 467.7 K to 465.8 K (-0.41 %) |
| Feb 02 2007 | EICU | VISICU INC | Rosenfeld Brian A | EVP and CMO | Sell | S | 10.40 | 1,875 | 19,500 | 467,700 | 469.6 K to 467.7 K (-0.40 %) |
| Feb 02 2007 | EICU | VISICU INC | Rosenfeld Brian A | EVP and CMO | Sell | S | 10.41 | 225 | 2,342 | 469,575 | 469.8 K to 469.6 K (-0.05 %) |
| Feb 02 2007 | EICU | VISICU INC | Rosenfeld Brian A | EVP and CMO | Sell | S | 10.42 | 100 | 1,042 | 469,800 | 469.9 K to 469.8 K (-0.02 %) |
| Feb 02 2007 | EICU | VISICU INC | Rosenfeld Brian A | EVP and CMO | Sell | S | 10.43 | 100 | 1,043 | 469,900 | 470 K to 469.9 K (-0.02 %) |
| Feb 02 2007 | EICU | VISICU INC | Estrada Vincent E | Sr VP and CFO | Option Exercise | M | 1.80 | 4,000 | 7,200 | 309,000 | |
| Feb 02 2007 | EICU | VISICU INC | Estrada Vincent E | Sr VP and CFO | Option Exercise | A | 10.18 | 30,000 | 305,400 | 30,000 | |
| Feb 02 2007 | EICU | VISICU INC | Estrada Vincent E | Sr VP and CFO | Sell | S | 10.24 | 400 | 4,096 | 0 | 400 to 0 (-100.00 %) |
| Feb 02 2007 | EICU | VISICU INC | Estrada Vincent E | Sr VP and CFO | Sell | S | 10.26 | 400 | 4,104 | 400 | 800 to 400 (-50.00 %) |
| Feb 02 2007 | EICU | VISICU INC | Estrada Vincent E | Sr VP and CFO | Sell | S | 10.27 | 200 | 2,054 | 800 | 1,000 to 800 (-20.00 %) |
| Feb 02 2007 | EICU | VISICU INC | Estrada Vincent E | Sr VP and CFO | Sell | S | 10.29 | 200 | 2,058 | 1,000 | 1.2 K to 1,000 (-16.67 %) |
| Feb 02 2007 | EICU | VISICU INC | Estrada Vincent E | Sr VP and CFO | Sell | S | 10.30 | 800 | 8,240 | 1,200 | 2 K to 1.2 K (-40.00 %) |
| Feb 02 2007 | EICU | VISICU INC | Estrada Vincent E | Sr VP and CFO | Sell | S | 10.35 | 400 | 4,140 | 2,000 | 2.4 K to 2 K (-16.67 %) |
| Feb 02 2007 | EICU | VISICU INC | Estrada Vincent E | Sr VP and CFO | Sell | S | 10.38 | 400 | 4,152 | 2,400 | 2.8 K to 2.4 K (-14.29 %) |
| Feb 02 2007 | EICU | VISICU INC | Estrada Vincent E | Sr VP and CFO | Sell | S | 10.39 | 600 | 6,234 | 2,800 | 3.4 K to 2.8 K (-17.65 %) |
| Feb 02 2007 | EICU | VISICU INC | Estrada Vincent E | Sr VP and CFO | Sell | S | 10.42 | 300 | 3,126 | 3,400 | 3.7 K to 3.4 K (-8.11 %) |
| Feb 02 2007 | EICU | VISICU INC | Estrada Vincent E | Sr VP and CFO | Sell | S | 10.45 | 300 | 3,135 | 3,700 | 4 K to 3.7 K (-7.50 %) |
| Feb 02 2007 | EICU | VISICU INC | Estrada Vincent E | Sr VP and CFO | Buy | M | 1.80 | 4,000 | 7,200 | 4,000 | 0 to 4 K |
| Feb 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Option Exercise | A | 10.18 | 65,000 | 661,700 | 65,000 | |
| Feb 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.23 | 500 | 5,115 | 380,000 | 380.5 K to 380 K (-0.13 %) |
| Feb 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.27 | 50 | 514 | 380,500 | 380.6 K to 380.5 K (-0.01 %) |
| Feb 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.28 | 500 | 5,140 | 380,550 | 381.1 K to 380.6 K (-0.13 %) |
| Feb 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.31 | 1,700 | 17,527 | 381,050 | 382.8 K to 381.1 K (-0.44 %) |
| Feb 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.34 | 250 | 2,585 | 382,750 | 383 K to 382.8 K (-0.07 %) |
| Feb 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.36 | 250 | 2,590 | 383,000 | 383.3 K to 383 K (-0.07 %) |
| Feb 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.37 | 500 | 5,185 | 383,250 | 383.8 K to 383.3 K (-0.13 %) |
| Feb 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.38 | 100 | 1,038 | 383,750 | 383.9 K to 383.8 K (-0.03 %) |
| Feb 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.39 | 700 | 7,273 | 383,850 | 384.6 K to 383.9 K (-0.18 %) |
| Feb 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.40 | 300 | 3,120 | 384,550 | 384.9 K to 384.6 K (-0.08 %) |
| Feb 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.42 | 150 | 1,563 | 384,850 | 385 K to 384.9 K (-0.04 %) |
| Feb 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.23 | 500 | 5,115 | 448,500 | 449 K to 448.5 K (-0.11 %) |
| Feb 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.27 | 50 | 514 | 449,000 | 449.1 K to 449 K (-0.01 %) |
| Feb 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.28 | 500 | 5,140 | 449,050 | 449.6 K to 449.1 K (-0.11 %) |
| Feb 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.31 | 1,700 | 17,527 | 449,550 | 451.3 K to 449.6 K (-0.38 %) |
| Feb 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.34 | 250 | 2,585 | 451,250 | 451.5 K to 451.3 K (-0.06 %) |
| Feb 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.36 | 250 | 2,590 | 451,500 | 451.8 K to 451.5 K (-0.06 %) |
| Feb 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.37 | 500 | 5,185 | 451,750 | 452.3 K to 451.8 K (-0.11 %) |
| Feb 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.38 | 100 | 1,038 | 452,250 | 452.4 K to 452.3 K (-0.02 %) |
| Feb 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.39 | 700 | 7,273 | 452,350 | 453.1 K to 452.4 K (-0.15 %) |
| Feb 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.40 | 300 | 3,120 | 453,050 | 453.4 K to 453.1 K (-0.07 %) |
| Feb 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.42 | 150 | 1,563 | 453,350 | 453.5 K to 453.4 K (-0.03 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.00 | 900 | 9,000 | 385,000 | 385.9 K to 385 K (-0.23 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.13 | 50 | 507 | 385,900 | 386 K to 385.9 K (-0.01 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.14 | 350 | 3,549 | 385,950 | 386.3 K to 386 K (-0.09 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.15 | 295 | 2,994 | 386,300 | 386.6 K to 386.3 K (-0.08 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.16 | 100 | 1,016 | 386,595 | 386.7 K to 386.6 K (-0.03 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.17 | 250 | 2,543 | 386,695 | 386.9 K to 386.7 K (-0.06 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.18 | 350 | 3,563 | 386,945 | 387.3 K to 386.9 K (-0.09 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.19 | 55 | 560 | 387,295 | 387.4 K to 387.3 K (-0.01 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.21 | 200 | 2,042 | 387,350 | 387.6 K to 387.4 K (-0.05 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.22 | 100 | 1,022 | 387,550 | 387.7 K to 387.6 K (-0.03 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.00 | 900 | 9,000 | 453,500 | 454.4 K to 453.5 K (-0.20 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.13 | 50 | 507 | 454,400 | 454.5 K to 454.4 K (-0.01 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.14 | 350 | 3,549 | 454,450 | 454.8 K to 454.5 K (-0.08 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.15 | 294 | 2,984 | 454,800 | 455.1 K to 454.8 K (-0.06 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.16 | 100 | 1,016 | 455,094 | 455.2 K to 455.1 K (-0.02 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.17 | 250 | 2,543 | 455,194 | 455.4 K to 455.2 K (-0.05 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.18 | 350 | 3,563 | 455,444 | 455.8 K to 455.4 K (-0.08 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.19 | 56 | 571 | 455,794 | 455.9 K to 455.8 K (-0.01 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.21 | 200 | 2,042 | 455,850 | 456.1 K to 455.9 K (-0.04 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.22 | 100 | 1,022 | 456,050 | 456.2 K to 456.1 K (-0.02 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.24 | 50 | 512 | 387,650 | 387.7 K to 387.7 K (-0.01 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.25 | 50 | 513 | 387,700 | 387.8 K to 387.7 K (-0.01 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.26 | 50 | 513 | 387,750 | 387.8 K to 387.8 K (-0.01 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.27 | 13 | 134 | 387,800 | 387.8 K to 387.8 K (0.00 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.28 | 50 | 514 | 387,813 | 387.9 K to 387.8 K (-0.01 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.29 | 100 | 1,029 | 387,863 | 388 K to 387.9 K (-0.03 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.30 | 250 | 2,575 | 387,963 | 388.2 K to 388 K (-0.06 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.31 | 50 | 516 | 388,213 | 388.3 K to 388.2 K (-0.01 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.32 | 50 | 516 | 388,263 | 388.3 K to 388.3 K (-0.01 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.34 | 50 | 517 | 388,313 | 388.4 K to 388.3 K (-0.01 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.35 | 100 | 1,035 | 388,363 | 388.5 K to 388.4 K (-0.03 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.36 | 200 | 2,072 | 388,463 | 388.7 K to 388.5 K (-0.05 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.38 | 150 | 1,557 | 388,663 | 388.8 K to 388.7 K (-0.04 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.39 | 50 | 520 | 388,813 | 388.9 K to 388.8 K (-0.01 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.49 | 137 | 1,437 | 388,863 | 389 K to 388.9 K (-0.04 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.24 | 50 | 512 | 456,150 | 456.2 K to 456.2 K (-0.01 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.25 | 50 | 513 | 456,200 | 456.3 K to 456.2 K (-0.01 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.26 | 50 | 513 | 456,250 | 456.3 K to 456.3 K (-0.01 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.27 | 13 | 134 | 456,300 | 456.3 K to 456.3 K (0.00 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.28 | 50 | 514 | 456,313 | 456.4 K to 456.3 K (-0.01 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.29 | 100 | 1,029 | 456,363 | 456.5 K to 456.4 K (-0.02 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.30 | 250 | 2,575 | 456,463 | 456.7 K to 456.5 K (-0.05 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.31 | 50 | 516 | 456,713 | 456.8 K to 456.7 K (-0.01 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.32 | 50 | 516 | 456,763 | 456.8 K to 456.8 K (-0.01 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.34 | 50 | 517 | 456,813 | 456.9 K to 456.8 K (-0.01 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.35 | 100 | 1,035 | 456,863 | 457 K to 456.9 K (-0.02 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.36 | 200 | 2,072 | 456,963 | 457.2 K to 457 K (-0.04 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.38 | 150 | 1,557 | 457,163 | 457.3 K to 457.2 K (-0.03 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.39 | 50 | 520 | 457,313 | 457.4 K to 457.3 K (-0.01 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.49 | 137 | 1,437 | 457,363 | 457.5 K to 457.4 K (-0.03 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.53 | 50 | 527 | 389,000 | 389.1 K to 389 K (-0.01 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.57 | 41 | 433 | 389,050 | 389.1 K to 389.1 K (-0.01 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.72 | 50 | 536 | 389,091 | 389.1 K to 389.1 K (-0.01 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.76 | 9 | 97 | 389,141 | 389.2 K to 389.1 K (0.00 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.80 | 200 | 2,160 | 389,150 | 389.4 K to 389.2 K (-0.05 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.85 | 50 | 543 | 389,350 | 389.4 K to 389.4 K (-0.01 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.87 | 50 | 544 | 389,400 | 389.5 K to 389.4 K (-0.01 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.98 | 50 | 549 | 389,450 | 389.5 K to 389.5 K (-0.01 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 11.00 | 50 | 550 | 389,500 | 389.6 K to 389.5 K (-0.01 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 11.01 | 50 | 551 | 389,550 | 389.6 K to 389.6 K (-0.01 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 11.08 | 100 | 1,108 | 389,600 | 389.7 K to 389.6 K (-0.03 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 11.11 | 50 | 556 | 389,700 | 389.8 K to 389.7 K (-0.01 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 11.14 | 50 | 557 | 389,750 | 389.8 K to 389.8 K (-0.01 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 11.19 | 150 | 1,679 | 389,800 | 390 K to 389.8 K (-0.04 %) |
| Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 11.21 | 50 | 561 | 389,950 | 390 K to 390 K (-0.01 %) |